Cerevance Lands $36,000,000 Series A Financing

  • Feed Type
  • Date
    12/6/2016
  • Company Name
    Cerevance
  • Mailing Address
    One Kendall Square Cambridge, MA 02139 USA
  • Company Description
    Cerevance is a neuroscience company focused on discovering and developing novel therapeutics for neurological and psychiatric disorders.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $36,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Takeda Ventures
  • Venture Investor
    Lightstone Ventures

Trending on Xconomy